New patent for Myovant Sciences drug MYFEMBREE

Copyright © DrugPatentWatch. Originally published at https://www.drugpatentwatch.com/blog/

Annual Drug Patent Expirations for MYFEMBREE
Annual Drug Patent Expirations for MYFEMBREE

Myfembree is a drug marketed by Myovant Sciences and is included in one NDA. It is available from one supplier. There are six patents protecting this drug.

MYFEMBREE drug price trends.

This drug has eigthy-six patent family members in thirty-three countries.

The generic ingredient in MYFEMBREE is estradiol; norethindrone acetate; relugolix. One supplier is listed for this compound. Additional details are available on the estradiol; norethindrone acetate; relugolix profile page.

For more information on how DrugPatentWatch can help with your pharmaceutical business intelligence needs, contact admin@DrugPatentWatch.com or visit www.DrugPatentWatch.com

Make Better Decisions with DrugPatentWatch

» Start Your Free Trial Today «

Copyright © DrugPatentWatch. Originally published at
DrugPatentWatch - Make Better Decisions
Scroll to Top